Clinical Trials Directory

Trials / Completed

CompletedNCT03505489

The Effect of Deep Inhalation on Mannitol Responsiveness

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
26 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study will assess how the inhalation technique used (deep inhalations versus tidal breathing) influences the results of a mannitol challenge test and a methacholine challenge test, if at all.

Detailed description

This study will look at airway responsiveness to inhaled methacholine and mannitol administered with and without deep inhalation. This study will also investigate the role of airway inflammation on these responses, using sputum differential cell counts and fractional exhaled nitric oxide. This is a single center, open label, randomized study. Individuals with stable asthma will be eligible for enrollment. The study will consist of two parts, screening and testing. Part 1: Screening Participants will undergo consent procedures and assessments of fractional exhaled nitric oxide levels, airway responsiveness to methacholine and sputum induction. If participants show airway responsiveness to methacholine (i.e. methacholine PC20 16mg/mL), they will be scheduled to undergo the testing part of the study. Part 2: Testing Participants will be randomized to undergo two methacholine or two mannitol challenges. Further randomization will occur with respect to whether the standard challenge method or the modified challenge method is performed first.

Conditions

Interventions

TypeNameDescription
PROCEDUREDeep inhalation techniqueUse of deep inhalations for administration of inhalant
PROCEDURETidal breathing techniqueUse of tidal breathing for administration of inhalant
DRUGMethacholineMethacholine direct bronchoconstrictor used for bronchoprovocation challenge
DRUGMannitolMannitol indirect bronchoconstrictor used for bronchoprovocation challenge

Timeline

Start date
2018-06-01
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2018-04-23
Last updated
2019-05-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03505489. Inclusion in this directory is not an endorsement.